Spyre Therapeutics Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Spyre Therapeutics, Inc. (SYRE)

43.14 -0.01 (-0.02%) USD | NASDAQ | Feb 27, 14:32

View Preferred Securities out of Shareholders Equity (Quarterly) for SYRE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

PTC Therapeutics, Inc.	--
Tandem Diabetes Care, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--